Navigation Links
ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
Date:3/18/2011

an unmet medical need, and providing rewarding careers to employees.  ViroPharma commercializes Cinryze® (C1 esterase inhibitor [human]) in the U.S. for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE).  ViroPharma commercializes Vancocin®, approved in the U.S. for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information on ViroPharma's commercial products, please download the package inserts at http://www.viropharma.com/Products.aspx).  ViroPharma currently focuses its drug development activities in diseases including C1 esterase inhibitor deficiency and C. difficile infection.

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's website, http://www.viropharma.com/. The company encourages investors to consult these sections for more information on ViroPharma and our business.

Forward Looking Statements

Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide our current expectations or forecasts of future events, including our regulatory filings in Europe related to Cinryze, including without limitation statements related to potential regulatory timelines, the likelihood of regulatory success including our ability to address the questions regarding our relationship with Sanquin and the scope of indications for which Cinryze may be approved. The EC may view the data regarding the use of Cinryze for acute treatment and / or prevention of HAE we hav
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2, 2015 The North ... the concerned market with analysis and forecast of ... in 2014, and is estimated to reach $632.5 ... from 2014 to 2019. Browse through ... for an analysis of industry trends and segments, ...
(Date:6/2/2015)... June 2, 2015 BioDelivery Sciences International, Inc. (NASDAQ: ... presentation by Dr. Mark A. Sirgo , President and ... PM Eastern time. Jefferies 2015 Global Healthcare Conference ... New York City , NY ... at www.bdsi.com .  For those who are not available ...
(Date:6/2/2015)... BOSTON , June 2, 2015  Only a ... very confident managing the patients they prescribe them to, ... Boston University School of Medicine (BUSM) and ... Daniel Alford, M.D. , director of ... of Pain) program , said, "This indicates a critical ...
Breaking Medicine Technology:North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 2North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 3BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 3Survey Results Show Few Doctors Are Very Confident Managing Patients on Opioids 2
... , NEWPORT COAST, Calif. , Jan. ... announced the donation of a Fraxel re:store laser system to the ... a worldwide leader in innovative treatment and care for burn patients ... reduce the appearance of scarring caused by traumatic thermal damage. , ...
... In conjunction with its fourth quarter 2009 earnings release (expected to ... CVD ) is pleased to invite you to listen to ... Internet on Thursday, January 28, 2010 at 9:00 a.m. ET. , , ... Slide Presentation, When: January 28, 2010, 9:00 a.m. ...
Cached Medicine Technology:Solta Medical Donates Fraxel re:store(R) Laser System to Grossman Burn Foundation 2Solta Medical Donates Fraxel re:store(R) Laser System to Grossman Burn Foundation 3
(Date:6/3/2015)... 2015 Foot and Ankle Specialists ... Friske ( Clarksville Division ) was recently presented ... of Advanced Wound Care (SAWC) and the American Podiatric ... Davis. The Conference was held on April 29-May ... in San Antonio, TX. , Dr. Casey Friske ...
(Date:6/3/2015)... Veatch Consulting Services is excited to announce ... for business in April 2006, they have made it ... clients. Each and every year they have worked diligently ... to say that they are off to a great ... added this year is the Customer Review site veatchconsultingreviews.weebly.com. ...
(Date:6/3/2015)... Israel (PRWEB) June 03, 2015 ... emergency mass-notification, multi-channel solutions, reported of its "behind-the-scenes" ... the past few months. Since March this year, ... has been inflicting the South-American country, putting millions ... ash and gas into the atmosphere. "evigilo's technology, ...
(Date:6/2/2015)... 2015 BALTIMORE, Md. – Ellarea ... book about wellness after being diagnosed with lupus. In ... through lifestyle changes which enhance health, lupus and other ... A Wellspring for Wellness ,” she offers a holistic ... This book provides an overview of some autoimmune diseases—especially ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 The organic ... Cotton Market Report, an annual study conducted by Textile ... sustainable textile industry. The report, released today, encompasses extensive ... on a worldwide level and also takes the opportunity ... cotton market. , The last several years ...
Breaking Medicine News(10 mins):Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Receives Award at the Spring 2015 Symposium of Advanced Wound Care Conference 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 3Health News:Thousands of Lives Saved, Millions Protected in Chile 2Health News:New book offers holistic approach in living with autoimmune diseases 2Health News:New book offers holistic approach in living with autoimmune diseases 3Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 2Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 3Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 4Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 5
... symptoms showed dramatic improvements with fish oil supplements in ... ran a trial on 25 teenagers who had been ... with a combination of omega-3 fish and omega-6 evening ... ,94% of these students aged 12 to 15 ...
... study conducted by Jiahai Lu, Ph.D., of the school ... passive immunotherapy// is the best way to treat highly ... uses antibodies from horses. Purified antibodies to the ... were used against mice and it proved effective in ...
... Jalgaon is in the eye of the storm once ... of Jalgaon district in Maharashtra. Following the bird-flu notification// ... week of March, samples were sent to High Security ... seven samples had tested positive for the H5 virus. ...
... nanotechnology has been developed at Leeds that will benefit ... surgery and for the next generation// of miniaturized computers. ... Professor Richard Williams and Dr Yulong Ding have created ... than other liquids. In a central heating system, nanofluids ...
... Pacific Islands, which consists of the some of the ... global conservation map//, and is said to be the ... ,Martin Puta Tofinga, Minister of Environment, Lands ... the establishment of the Phoenix Islands Protected Area at ...
... of Food Technology magazine designer foods and functional ... mention of micro and macro nutrients// nanonutrients are ... in nanotechnology show great potential for positively influencing ... facilitating the controlled release and protecting the stability ...
Cached Medicine News:Health News:Passive Immunotherapy Could Prevent Avian Flu from Affecting Humans 2Health News:Phoenix Islands To Be Protected Under Global Conservation Map 2Health News:Phoenix Islands To Be Protected Under Global Conservation Map 3
This monitor is designed specifically for medical applications and is UL2601-1 listed....
Camera and light source in one compact "Plug-and-Play" device....
... Components, LLC offers high ... "Made in Germany". All ... according to ISO 9001 ... excellent design elements for ...
... analysis with the WASCA Analyzer provides youwith ... existing diagnostic techniques, the WASCA Analyzeranalyzes the ... from thecornea to the retina. In addition ... supplies higher order aberrations which were largely ...
Medicine Products: